{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:51:01Z","timestamp":1792011061300,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1159\/000084492","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T04:57:17Z","timestamp":1110949037000},"page":"67-74","source":"Crossref","is-referenced-by-count":16,"title":["Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations"],"prefix":"10.1016","volume":"5","author":[{"given":"Jennifer F.","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernandez-del","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Rattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Warshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1159\/000084492_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1159\/000084492_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM199202133260706","article-title":"Pancreatic carcinoma","volume":"326","author":"Warshaw","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1159\/000084492_bib3","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1200\/JCO.1998.16.7.2548","article-title":"Cancer gene therapy: Connecting basic research with clinical inquiry","volume":"16","author":"Dranoff","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1159\/000084492_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.8493530","article-title":"The basic science of gene therapy","volume":"260","author":"Mulligan","year":"1993","journal-title":"Science"},{"key":"10.1159\/000084492_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1055-3207(02)00023-6","article-title":"Gene therapy in pancreatic cancer","volume":"11","author":"Tseng","year":"2002","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1159\/000084492_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.186.5.645","article-title":"Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy","volume":"186","author":"Speiser","year":"1997","journal-title":"J Exp Med"},{"key":"10.1159\/000084492_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0039-6060(96)80285-6","article-title":"Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines","volume":"120","author":"Clary","year":"1996","journal-title":"Surgery"},{"key":"10.1159\/000084492_bib8","first-page":"925s","article-title":"Systemic and local immunosup-pression in pancreatic cancer patients","volume":"7","author":"von Bernstorff","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1159\/000084492_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1615\/CritRevImmunol.v20.i5.20","article-title":"Immune cell functions in pancreatic cancer","volume":"20","author":"Plate","year":"2000","journal-title":"Crit Rev Immunol"},{"key":"10.1159\/000084492_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s004230050233","article-title":"Tumor size and lymph-node status in pancreatic carcinoma \u2014 Is there a correlation to the preoperative immune function?","volume":"384","author":"Wenger","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"10.1159\/000084492_bib11","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1089\/hum.1998.9.13-1951","article-title":"A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma","volume":"9","author":"Jaffee","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1159\/000084492_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/314582","article-title":"Normal IgG and impaired IgM responses to poly-saccharide vaccines in asplenic patients","volume":"179","author":"Molrine","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1159\/000084492_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1701424","article-title":"Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation","volume":"22","author":"Vance","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1159\/000084492_bib14","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T","article-title":"Antigen-specific antibody responses in lupus patients following immunization","volume":"41","author":"Battafarano","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1159\/000084492_bib15","series-title":"Current Protocols in Immunology","year":"1996"},{"key":"10.1159\/000084492_bib16","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.95.22.13141","article-title":"Vaccination with irradiated autologous melanoma cells engineered to secrete human granu-locyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma","volume":"95","author":"Soiffer","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000084492_bib17","first-page":"1537","article-title":"Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer","volume":"57","author":"Simons","year":"1997","journal-title":"Cancer Res"},{"key":"10.1159\/000084492_bib18","first-page":"5160","article-title":"Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete gran-ulocyte-macrophage colony-stimulating factor using ex vivo gene transfer","volume":"59","author":"Simons","year":"1999","journal-title":"Cancer Res"},{"key":"10.1159\/000084492_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(98)07186-4","article-title":"Active specific immunothera-py for stage II and stage III human colon cancer: A randomised trial","volume":"353","author":"Vermorken","year":"1999","journal-title":"Lancet"},{"key":"10.1159\/000084492_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"10.1159\/000084492_bib21","first-page":"639","article-title":"The c-K-ras gene and human cancer","volume":"7","author":"Kahn","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1159\/000084492_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","article-title":"Novel allogeneic granu-locyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation","volume":"19","author":"Jaffee","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1159\/000084492_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/annonc\/10.suppl_4.S4","article-title":"Progress in cancer genetics: Lessons from pancreatic cancer","volume":"10","author":"Goggins","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1159\/000084492_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00006676-199707000-00006","article-title":"Different expression of transforming growth factor beta 1 in pancreatic ductal adenocarci-noma and cystic neoplasms","volume":"15","author":"Van Laethem","year":"1997","journal-title":"Pancreas"},{"key":"10.1159\/000084492_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006676-200004000-00002","article-title":"The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice","volume":"20","author":"Sunamura","year":"2000","journal-title":"Pancreas"},{"key":"10.1159\/000084492_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.2001.01628.x","article-title":"In-terferon-gamma administration after abdominal surgery rescues antigen-specific helper T cell immune reactivity","volume":"125","author":"Rentenaar","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1159\/000084492_bib27","doi-asserted-by":"crossref","first-page":"931942","DOI":"10.1023\/A:1022260711583","article-title":"MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment","volume":"18","author":"Mukherjee","year":"2001","journal-title":"Glycoconj J"},{"key":"10.1159\/000084492_bib28","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.165.6.3451","article-title":"Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred","volume":"165","author":"Mukherjee","year":"2000","journal-title":"J Immunol"},{"key":"10.1159\/000084492_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1749-6632.1976.tb41664.x","article-title":"Immunocompetence, immunodeficiency and prognosis in cancer","volume":"276","author":"Hersh","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1159\/000084492_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0091-6749(77)90139-7","article-title":"Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids","volume":"60","author":"Galant","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1159\/000084492_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0090-1229(85)90064-9","article-title":"Assessment of delayed-type hypersensitivity in man: A comparison of the \u2018Multitest\u2019 and conventional intradermal injection of six antigens","volume":"35","author":"Frazer","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1159\/000084492_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jso.2930140405","article-title":"Specific and aspecific immune responsiveness in lung cancer patients: Cutaneous delayed hypersensitiv-ity reactions to a lung cancer-associated antigen","volume":"14","author":"Sega","year":"1980","journal-title":"J Surg Oncol"},{"key":"10.1159\/000084492_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000658-198907000-00011","article-title":"Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response variables","volume":"210","author":"Christou","year":"1989","journal-title":"Ann Surg"},{"key":"10.1159\/000084492_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000658-199522240-00011","article-title":"The delayed hypersensitivity response and host resistance in surgical patients: 20 years later","volume":"222","author":"Christou","year":"1995","journal-title":"Ann Surg"},{"key":"10.1159\/000084492_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1016009317796","article-title":"Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients","volume":"74","author":"Schiffman","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1159\/000084492_bib36","first-page":"1347","article-title":"Delayed-type hy-persensitivity response is a predictor of peripheral blood T-cell immunity after HER-2\/neu peptide immunization","volume":"6","author":"Disis","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1159\/000084492_bib37","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19921015)70:8<2192::AID-CNCR2820700830>3.0.CO;2-6","article-title":"Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors","volume":"70","author":"Pollock","year":"1992","journal-title":"Cancer"},{"key":"10.1159\/000084492_bib38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1097-0142(197010)26:4<884::AID-CNCR2820260422>3.0.CO;2-S","article-title":"Immunosuppression by 5-fluorouracil","volume":"26","author":"Mitchell","year":"1970","journal-title":"Cancer"},{"key":"10.1159\/000084492_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/cncr.10757","article-title":"Gemcitabine and platinum combinations in pancreatic cancer","volume":"95","author":"Philip","year":"2002","journal-title":"Cancer"},{"key":"10.1159\/000084492_bib40","first-page":"1450","article-title":"Gemcitabine and protracted 5-FU for advanced pancreatic cancer: A phase II study","volume":"47","author":"Kurtz","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1159\/000084492_bib41","first-page":"104","article-title":"The effects of nutrition and treatment of cancer on host immunocompetence","volume":"148","author":"Ota","year":"1979","journal-title":"Surg Gynecol Obstet"},{"key":"10.1159\/000084492_bib42","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/1097-0142(197606)37:6<2792::AID-CNCR2820370634>3.0.CO;2-Z","article-title":"Immune evaluation of lung cancer patients undergoing radiation therapy","volume":"37","author":"Stefani","year":"1976","journal-title":"Cancer"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390305800390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390305800390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T20:25:41Z","timestamp":1549225541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390305800390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1424390305800390"],"URL":"https:\/\/doi.org\/10.1159\/000084492","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}